Cholangiocarcinoma in Denmark: Time-trends in incidence and mortality
Cholangiocarcinomas have a poor prognosis, and the incidence is rising in most countries. In Europe, all countries but Denmark have shown an increasing incidence of intrahepatic cholangiocarcinoma. The incidence of cholangiocarcinoma in Denmark between 1995 and 2022 increased, driven by a large increase in intrahepatic cholangiocarcinomas. The proportion with localised resectable disease increased while 1-year mortality decreased, though it remained high (65% in 2019-2022). Knowledge of incidence and mortality risk is valuable for doctors to understand the disease, identify risk factors, and design preventive care studies; for healthcare providers to allocate resources; and for patients to understand their prognosis.
Authors
- Frank Viborg Mortensen (ORCID: https://orcid.org/0000-0001-7580-8037)
- Britta Weber (ORCID: https://orcid.org/0000-0002-7099-1204)
- Joe West (ORCID: https://orcid.org/0000-0002-1135-9356)
- Peter Jepsen (ORCID: https://orcid.org/0000-0002-6641-1430)
- Morten Daniel Jensen (ORCID: https://orcid.org/0000-0002-5137-7268)
Institutions
- Nottingham University Hospitals NHS Trust (GB)
- University of Nottingham (GB)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Nottingham Biomedical Research Centre (GB)
Publication Details
- Journal
- JHEP Reports
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1016/j.jhepr.2025.101493
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Aarhus Universitet
- Novo Nordisk
- Novo Nordisk Fonden
- Sundhedsvidenskabelige Fakultet, Aarhus Universitet